Jeffrey A. Blatnik
Washington University in St. Louis, University Hospitals Cleveland Medical Center
Papers
12
Total Citations
328
H-Index
7
About
Dr. Jeffrey A. Blatnik is a leading figure in hernia surgery, whose work has fundamentally shaped the modern approach to abdominal wall reconstruction. His primary research focuses on advancing minimally invasive techniques, particularly through rigorous clinical trials comparing robotic and laparoscopic hernia repair. Dr. Blatnik’s most impactful contribution is the landmark RIVAL trial—the first multicenter randomized clinical trial to compare robotic inguinal hernia repair to the laparoscopic standard. This seminal work, published in 2020 with nearly 200 citations, provided crucial level I evidence on outcomes and recovery, directly informing surgical practice worldwide. He has also made significant contributions to complex hernia repair, including the use of transversus abdominis release (TAR) and novel bioabsorbable meshes. Beyond clinical outcomes, Dr. Blatnik is pioneering the integration of force feedback technology in robotic surgery, addressing a critical limitation of the platform. His extensive body of work, encompassing over 300 citations, has established him as a key authority on evidence-based, minimally invasive hernia surgery, consistently challenging conventions to improve patient care.
Research Focus
Key Achievements
Top Papers
- 1Robotic Inguinal vs Transabdominal Laparoscopic Inguinal Hernia Repair197 citations · 2020
- 2
- 3Controversies and Techniques in the Repair of Abdominal Wall Hernias22 citations · 2018
- 4
- 5Advances in Minimally Invasive Surgery in Pediatrics15 citations · 2010
- 6
- 7
- 8Robotic Parastomal Hernia Repair: Modified Retromuscular Sugarbaker7 citations · 2020
- 9
- 10